| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | Sep 17, 2024 | C4 Therapeutics, Inc. | Chief Scientific Officer | Sell | 50.0 | -661 | -0.50% | ✗ | $4.2K |
| Feb 13, 2024 | Feb 15, 2024 | C4 Therapeutics, Inc. | Chief Scientific Officer | Sell | 91.3 | +25,045 | 24.06% | ✗ | $14.7K |
| Aug 30, 2023 | Aug 31, 2023 | C4 Therapeutics, Inc. | Chief Scientific Officer | Sell | 50.0 | -661 | -0.63% | ✗ | $1.9K |
| Jan 30, 2023 | Feb 1, 2023 | C4 Therapeutics, Inc. | Chief Scientific Officer | Sell | 46.3 | -1,301 | -1.67% | ✗ | $10.1K |
| May 26, 2022 | Jun 14, 2022 | C4 Therapeutics, Inc. | Chief Scientific Officer | Sell | 47.5 | -1,102 | -1.47% | ✗ | $7.7K |
| Aug 3, 2021 | Aug 5, 2021 | C4 Therapeutics, Inc. | Chief Scientific Officer | Sell | 7.5 | -17,057 | -42.86% | ✓ | $767.8K |
| Jul 29, 2021 | Aug 2, 2021 | C4 Therapeutics, Inc. | Chief Scientific Officer | Sell | 5.0 | -68,315 | -63.19% | ✓ | $3.1M |